Greg Dean
AeroLeads people directory · profile

Greg Dean Email & Phone Number

Brain Injury Survivor Raising Awareness at Voluntary
Location: Greater Cambridge Area, United Kingdom, United Kingdom 10 work roles 3 schools
1 work email found @medimmune.com LinkedIn matched
✓ Verified May 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email

Work email d****@medimmune.com
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Brain Injury Survivor Raising Awareness
Location
Greater Cambridge Area, United Kingdom, United Kingdom
Company size

Who is Greg Dean? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Greg Dean is listed as Brain Injury Survivor Raising Awareness at Voluntary, a company with 339 employees, based in Greater Cambridge Area, United Kingdom, United Kingdom. AeroLeads shows a work email signal at medimmune.com and a matched LinkedIn profile for Greg Dean.

Greg Dean previously worked as Brain Injury Awareness Advocate at Voluntary and Board Trustee & Company Secretary Headway Cambridgeshire at Headway Cambridgeshire. Greg Dean holds Ph.D., Plant Microbe Interactions from John Innes Centre.

Company email context

Email format at Voluntary

This section adds company-level context without repeating Greg Dean's masked contact details.

{last}{first_initial}@medimmune.com
86% confidence

AeroLeads found 1 current-domain work email signal for Greg Dean. Compare company email patterns before reaching out.

Profile bio

About Greg Dean

Retired Biotech BioPharm Scientist raising awareness for those living with brain injuries

Listed skills include Cell Culture, Cell, Assay Development, Molecular Biology, and 13 others.

Current workplace

Greg Dean's current company

Company context helps verify the profile and gives searchers a useful next step.

Voluntary
Voluntary
Brain Injury Survivor Raising Awareness
Website
Employees
339
AeroLeads page
10 roles

Greg Dean work experience

A career timeline built from the work history available for this profile.

Brain Injury Awareness Advocate

Current

East Of England, London And Online

There is a continuing need to help improve understanding of what it means to live with a brain injury within our society today. Brain injury can be a very much hidden disability or a disability that people can easily misunderstand. The need therefore is great for those that can to raise awareness, to give a personal perspective and to share experiences.

Aug 2021 - Present

Board Trustee & Company Secretary Headway Cambridgeshire

Headway Cambridgeshire

Cambridgeshire, England, United Kingdom

In the years following my sub-arachnoid brain haemorrhage, Headway Cambridgeshire through occupation health and group courses played a key role in helping me adapt and come to terms with the impact of my brain injury. The work they do in supporting both those with brain injuries and their family / carers provides critical support to so many that isn't.

May 2020 - Jul 2023

Change In Circumstance:

Cambridge, United Kingdom

As a lot of my closer colleagues will know I suffered a subarachnoid brain haemorrhage back in Jan of 2015. After three years of attempting a return to work, the long term effects of the brain injury have meant that I have to be realistic about what I can do on a day to day and re-think priorities. This unfortunately has meant I have to step back from an.

Jan 2018 - Nov 2022

Principal Scientist

Cambridge, UK

  • Currently I am working within the Cell Line Development team at the MedImmune Cambridge site whose function is to deliver recombinant cell lines suitable for early development, clinic and market supply of therapeutic.
  • Expression and cell line development platforms to aid and expedite the creation of cell lines for the expression of recombinant therapeutic proteins
  • The role of bioinformatics and… Show more Currently I am working within the Cell Line Development team at the MedImmune Cambridge site whose function is to deliver recombinant cell lines suitable for early development.
  • The role of bioinformatics and synthetic biology to help develop the next generation of cell lines to produce difficult to express / complex molecules more efficiently
  • Novel platforms to aid cloning and analysis of cell lines, for example microfluidic approaches Show less
May 2015 - Jan 2018

Senior Scientist

Headed up a team within the CLD group within Development at the MedImmune Cambridge site. Team is team focussed on the production of recombinant therapeutic antibody producing CHO cell lines suitable for early development, clinical and market supply. Current interests include the use of automation within the cell line development process.

Jun 2010 - May 2015

Senior R&D Manager

  • Responsible for managing a team within the Early Expression and Supply group part of Development at MedImmune Cambridge. Team responsibilities were split between two main functions:
  • Working closely with Discovery groups the team supported drug development activities by producing mg to gram amounts of antibody for in vitro and in vivo assays.
  • Providing assay support for the wider department, focussing on antibody quantitation.
Jun 2008 - Jun 2010

Senior Research Scientist

Role within the Cell Line Development team focussed on the production of recombinant therapeutic antibody producing CHO cell lines suitable for early development, clinical and market supply. A lead role responsible for multiple concurrent cell line development projects, ensuring technical, regulatory, and timeline project compliance.

Jun 2003 - Apr 2008

Research Scientist

Cambridge Antibody Technology

Evaluation and development of expression vector/cell lines, and subsequent screening platforms for the production of recombinant CHO and NS0 cell lines for the manufacture of therapeutic monoclonal antibodies. Technical development projects included the evaluation, development and implementation of screening platforms and strategies to isolate high.

Nov 1999 - Jun 2003

Senior Research Associate

“Transcriptional regulation of the human TIMP-1 gene: Mapping transcriptional control in intron-1.” Funded by the Arthritis Research Campaign. Project investigated the transcriptional control of the TIMP-1 gene focussing on the role of intronic regulation.

Oct 1996 - Sep 1999

Research Associate

“Production of pyruvate decarboxylase for substrate specificity studies.” Project focussed on the production and purification of private decarboxylase from Saccharomyces sp. and Zymonmonas mobilis.

Oct 1990 - Sep 1991
3 education records

Greg Dean education

Ph.D., Plant Microbe Interactions

John Innes Centre

“Analysis of bacterial secreted factors involved in initiation of symbiosis between Rhizobium sp. and their host legume partner.” The.

M.Sc. (Distinction), Biotechnology

“Over-expression studies of transcriptional control proteins.” Project focussed on the problems and optimisation of transgenes in E. coli..

FAQ

Frequently asked questions about Greg Dean

Quick answers generated from the profile data available on this page.

What company does Greg Dean work for?

Greg Dean works for Voluntary.

What is Greg Dean's role at Voluntary?

Greg Dean is listed as Brain Injury Survivor Raising Awareness at Voluntary.

What is Greg Dean's email address?

AeroLeads has found 1 work email signal at @medimmune.com for Greg Dean at Voluntary.

Where is Greg Dean based?

Greg Dean is based in Greater Cambridge Area, United Kingdom, United Kingdom while working with Voluntary.

What companies has Greg Dean worked for?

Greg Dean has worked for Voluntary, Headway Cambridgeshire, Medimmune, Cambridge Antibody Technology/Medimmune Ltd, and Cambridge Antibody Technology.

How can I contact Greg Dean?

You can use AeroLeads to view verified contact signals for Greg Dean at Voluntary, including work email, phone, and LinkedIn data when available.

What schools did Greg Dean attend?

Greg Dean holds Ph.D., Plant Microbe Interactions from John Innes Centre.

What skills is Greg Dean known for?

Greg Dean is listed with skills including Cell Culture, Cell, Assay Development, Molecular Biology, Antibodies, Protein Expression, Monoclonal Antibodies, and Purification.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.

People with similar names

Check these profiles if this is not the Greg Dean you were looking for.

View similar profiles